Expanding into a new market properly

• expand
• new country
• international
• another city
• new region
• localise

• What evidence exists that demand is there — enquiries, searches, referrals?
• What must change: language, price, compliance, delivery?
• Who owns it, and what else will they stop doing?
• What is the milestone that would justify continuing?

• inbound interest from that market
• regulatory or tax implications
• cost to serve there
• home-market {capacity} headroom

• Attention diverted from a working home market
• Compliance or delivery cost underestimated

• If
  There is already unsolicited demand
  Then
  Serve it manually first and measure before investing.
• If
  The home market is not saturated
  Then
  Expansion usually costs more than deepening. Justify it explicitly.
• If
  Compliance or tax obligations are unclear
  Then
  Get advice before selling anything there.

Serve three customers in the new market manually, at full price, and record the true cost to deliver.

Read after 60 days.

• Three delivered at acceptable margin
• No compliance surprise

• Cost to serve destroys margin
• Regulatory requirements exceed what the company can carry now

• Margin holds → Structure it as a milestone plan with a review date.
• It does not → Stop and record why, so it is not revisited on enthusiasm alone.

Aury can carry out: read company, prepare research brief, flag risk, file memory. Specialists involved: research, operations, finance.

Your approval: Selling into a new jurisdiction is a founder decision, taken with professional advice.

This needs tax review — get a qualified professional to look at your specifics before anything is signed or sent.

Applies where the offer can be delivered remotely or replicated locally.

Tax registration, consumer law, data protection and employment rules differ by jurisdiction. Aurygine has no jurisdiction-specific knowledge of your obligations and will not guess at them.

• Sourced operator experience: Founder/operator case study analysed inside Aurygine — bootstrapped B2B software company, 2026
• Aurygine synthesis: Aurygine synthesis across founder journeys

Confidence: low. Last reviewed 2026-08-25. Your company's own recorded results override this playbook whenever the two disagree.